Isodiol International Inc Share Price Other OTC
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 1.6B | Sales 2019 | 22.25M 1.86B | Capitalization | 49.96M 4.17B |
---|---|---|---|---|---|
Net income 2018 | -36M -3B | Net income 2019 | -126M -10.51B | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 1.3B | Net Debt 2019 | 5.22M 436M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/19/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/17/24 |
Director/Board Member | - | 30/18/30 | |
Director/Board Member | - | 21/18/21 |
1st Jan change | Capi. | |
---|---|---|
+44.36% | 6.34B | |
-13.52% | 4.61B | |
+10.85% | 3.39B | |
-6.52% | 3.29B | |
+51.14% | 2.02B | |
-5.22% | 1.73B | |
+1.29% | 1.67B | |
+57.69% | 1.63B | |
-9.67% | 1.59B |